As a multifaceted Global Healthcare CFO with over 20 years of experience, I have a proven track record of creating significant value for companies. My expertise spans Accounting and Finance, Strategic development, Investor relations, Business growth, Due diligence, and Operations. My unique perspective and ability to connect stakeholders, develop strategic roadmaps, optimize resources to enhance further value creation, drive company development, and deliver value for investors and shareholders.As a Turnaround expert and strategic partner to CEOs and Boards, I have a successful track record of driving pivotal decisions, including IPO market selection and timely IPO readiness, which secured crucial capital pivotal for the company's development and enabled its acquisition. I oversee corporate legal structures, tax planning, accounting, finance, FP&A, cash flow management, internal processes, policies, and risk management. Additionally, I've adeptly navigated complex international legal structures, tax/transfer pricing, IPO preparations, and regulatory compliances.Successful Records & Key Achievements:● Instrumental in catalyzing two IPOs with a combined value exceeding $3B+ through public offering, private financing, M&As, venture debt, and licensing and R&D partnership deals● Led Ambrx Biopharma's oversubscribed US$200 million in a crossover financing round with leading healthcare investors, including Fidelity, BlackRock, Cormorant, HBM Healthcare, Invus, and Adage Capital ● Team builder and problem solver, positioned the company for the US IPO and built the infrastructure to enable the company to be IPO-ready and post-IPO effective● Led Ambrx Biopharma's IPO and achieved a 5.7X oversubscribed IPO size of $148.5M, pivotal in setting the stage for the company's successful acquisition by Johnson & Johnson for $2 billion ● Led investor relations and roadshows, managed Board of Directors and Shareholders relationships/communications, and planned/executed board and shareholders meetings, presenting and implementing resolutions● Key player and internal lead for multiple strategic out-licensing and R&D partnership deals● Established solid and high-quality relationships with research analysts, top-tier bankers, investors, prominent pharma executives, and other global service providers to build a biotech company and expand the business ● Generated multiple million dollars in savings for the organization each year● Servied as Audit Committee, Compensation Committee, and Risk Management Committee member